Pay in 4 interest-free payments of $7.10 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
This 40-week study randomized participants to tirzepatide 5 mg, 10 mg, or 15 mg, or semaglutide 1 mg
SUV39H1 deficiency suppresses clear cell renal cell carcinoma growth by inducing ferroptosis
doi:10.1016/S0753-3322(03)00043-X
*Correspondence: Fei Mao, [email protected] These authors have contributed equally to this work Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Cresswell, J
US$ 22.73
US$ 28.86
US$ 27.46
US$ 25.89
